Purchase Order HT940625P0009
Award Date
2/21/25
Potential Completion Date
2/23/28
Potential Value
$215K
Federal Agency
Defense Health Agency
Awardee
Cerus Corporation
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Portsmouth, VA 23708, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price purchase order contract was awarded by the Defense Health Agency (DHA) to Cerus Corporation, a biomedical products company specializing in blood safety technologies and pathogen reduction systems. The $369,384 contract is for the provision of Cerus' proprietary INTERCEPT Blood System, which uses riboflavin and ultraviolet light to inactivate pathogens in blood components, including platelets and plasma. This pathogen reduction technology plays a critical role in reducing...
This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Cerus Corporation, a biomedical products company specializing in blood safety technologies. The contract is for the service and maintenance of the Cerus INTERCEPT Illuminator, which is a key component of the company's proprietary INTERCEPT Blood System. The INTERCEPT system uses riboflavin and ultraviolet light to inactivate pathogens in blood components, including platelets, plasma, and red blood cells,...
This federal contract award was issued by the Bureau of Medicine and Surgery, a defense agency, to Cerus Corporation, a biomedical products company specializing in blood safety technologies. The $138,800 firm-fixed-price contract is for the supply of INTERCEPT Illuminator 60 Hz equipment and INTERCEPT Platelet Processing Sets with Dual Storage, as well as related services, to support the agency's blood product safety requirements. Cerus Corporation's proprietary INTERCEPT Blood System uses...
This federal contract award with ID 75A50124C00046 was made by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Cerus Corporation, a for-profit manufacturer. The $188,446,002.15 cost-sharing contract is for the license of Cerus' proprietary Pathogen Reduction Technology (PRT) for red blood cell (RBC) components, with the goal of reducing the risk of transfusion-transmitted infections by recognized, emerging, epidemic, and endemic pathogens. This...
This is a firm fixed-price purchase order contract awarded by the Defense Health Agency (DHA) to Cerus Corporation, a biomedical products company specializing in blood safety technologies and pathogen reduction systems. The contract is for the INTERCEPT Platelet Processing Set and service maintenance, with a ceiling value of $193,882.00 and a period of performance from January 14, 2025 to September 30, 2027. The contract stems from a sole-source solicitation for the INTERCEPT Blood System...
The Department of the Navy Bureau of Medicine and Surgery awarded a firm fixed price purchase order contract to Cerus Corporation, a biomedical products manufacturer, for the ILLUMINATOR 60 HZ. The $119,534.60 contract has an October 10, 2017 completion date and was awarded on August 12, 2017. Cerus is a for-profit organization that has received over 20 prime federal contracts since 2002 to provide goods and services related to blood safety and pathogen reduction systems for agencies such as the...
This federal contract award, valued at $11,688.77, was issued by the Defense Health Agency (DHA) to Haemonetics Corporation, a leading medical technology company specializing in blood and plasma management solutions. The requirement is for the delivery of five cases of AS-3 300 ML solution per quarter over the base year plus two option years, which is used in the processing of frozen red blood cells for patient transfusions. This contract is a firm-fixed price purchase order and does not have...
This is a firm-fixed price purchase order awarded by the Defense Health Agency (DHA) to Haemonetics Corporation, a leading provider of blood and plasma supplies and services, for $30,688.30. The contract is for blood consumable supplies such as blood bags, tubing sets, reagents, and solutions. The award has an ultimate completion date of August 1, 2022 and does not utilize a set-aside. Haemonetics is the prime contractor and no subcontractors are identified. The DHA, which delivers integrated...
This federal contract award is for the procurement of WB CORQC BLOOD BANK REAGENTS by the Defense Health Agency (DHA), a Defense agency. The contract was awarded to Immucor Inc., a manufacturer of in vitro diagnostic products and solutions for blood transfusion and transplantation compatibility testing. The award, valued at $228,785.56, is structured as a Blanket Purchase Agreement (BPA) call with a firm fixed price. The contract does not have a set-aside designation and is expected to be...
This is a $27,460.00 Firm Fixed Price purchase order awarded by the Defense Health Agency (DHA) to Immucor Inc., a manufacturer of in vitro diagnostic supplies. The contract is for the delivery of 111801 HB 301 MICROCUVETTS, which are specialized disposable equipment used in blood typing and compatibility testing procedures. Immucor is a prime vendor to federal agencies, including the Department of Veterans Affairs and the Indian Health Service, for a range of blood banking and...